Volume 9 – Number 4

Elite HIV Controllers: Myth or Reality?

The Emergence of Peptides as Therapeutic Drugs for the Inhibition of HIV-1

Emerging Trends of HIV Epidemiology in Asia

Kaposi’s Sarcoma Revisited

Sexual Dysfunction in the Highly Active Antiretroviral Therapy Era

Treatment of Heavily Antiretroviral-Experienced HIV-Infected Patients

Denial of Expert Opinion in HIV Court Cases

New Trials Comparing Protease Inhibitors and Nonnucleoside Analogs will Assess Reductions in Cardiovascular Risk Besides Antiviral Efficacy in First-line Therapies

HIV Guidelines

HIV Conferences